Direct to Patient – The Future of Clinical Trials
Until recently, patients participating in clinical trials had to visit research centres regularly. Today, the Direct to Patient (DTP) model is transforming this process - medicines are now delivered directly to patients’ homes, safely and in full compliance with pharmaceutical regulations.
The DTP model, developed in line with pharmaceutical transport standards, ensures:
- Continuity of treatment and improved patient comfort,
- Reduced risk of logistical errors,
- Access to clinical trials for all patients, regardless of location or mobility.
At MediLogix, we manage each DTP shipment with precision - from selecting the correct temperature range and certified packaging to real-time GPS and temperature monitoring. After delivery, all data are archived and verified for full compliance with GDP procedures and the clinical protocol.
This advanced logistics solution increases the availability and safety of therapies, supports remote and personalised medicine, and strengthens the entire healthcare system.
At MediLogix, we believe the future of clinical research is patient-centred — and DTP logistics makes it possible.
Find out more about Direct to Patient (DTP) model provided by ADECON.